Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
Pharmacy Department, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
Appl Clin Inform. 2024 Mar;15(2):388-396. doi: 10.1055/s-0044-1786978. Epub 2024 May 16.
Antimicrobial dosing in critically ill patients is challenging and model-informed precision dosing (MIPD) software may be used to optimize dosing in these patients. However, few intensive care units (ICU) currently adopt MIPD software use.
To determine the usability of MIPD software perceived by ICU clinicians and identify implementation barriers and enablers of software in the ICU.
Clinicians (pharmacists and medical staff) who participated in a wider multicenter study using MIPD software were invited to participate in this mixed-method study. Participants scored the industry validated Post-study System Usability Questionnaire (PSSUQ, assessing software usability) and Technology Acceptance Model 2 (TAM2, assessing factors impacting software acceptance) survey. Semistructured interviews were used to explore survey responses. The framework approach was used to identify factors influencing software usability and integration into the ICU from the survey and interview data.
Seven of the eight eligible clinicians agreed to participate in the study. The PSSUQ usability scores ranked poorer than the reference norms (2.95 vs. 2.62). The TAM2 survey favorably ranked acceptance in all domains, except image. Qualitatively, key enablers to workflow integration included clear and accessible data entry, visual representation of recommendations, involvement of specialist clinicians, and local governance of software use. Barriers included rigid data entry systems and nonconformity of recommendations to local practices.
Participants scored the MIPD software below the threshold that implies good usability. Factors such as availability of software support by specialist clinicians was important to participants while rigid data entry was found to be a deterrent.
危重症患者的抗菌药物剂量调整具有挑战性,模型指导的精准药物剂量调整(MIPD)软件可用于优化这些患者的剂量。然而,目前很少有重症监护病房(ICU)采用 MIPD 软件。
确定 ICU 临床医生对 MIPD 软件的可用性感知,并确定 ICU 中软件实施的障碍和促进因素。
参与使用 MIPD 软件的更广泛多中心研究的临床医生(药剂师和医务人员)被邀请参与这项混合方法研究。参与者对行业验证的使用后系统可用性问卷(PSSUQ,评估软件可用性)和技术接受模型 2(TAM2,评估影响软件接受的因素)调查进行评分。半结构化访谈用于探索调查结果。采用框架方法从调查和访谈数据中确定影响软件可用性和整合到 ICU 的因素。
符合条件的 8 名临床医生中有 7 名同意参与研究。PSSUQ 可用性评分低于参考标准(2.95 与 2.62)。TAM2 调查在除形象外的所有领域都对接受程度进行了有利排名。定性分析表明,工作流程整合的主要促进因素包括清晰且易于访问的数据输入、建议的可视化表示、专科临床医生的参与以及软件使用的本地治理。障碍包括僵化的数据输入系统和建议与本地实践的不一致。
参与者对 MIPD 软件的评分低于表示良好可用性的阈值。临床医生提供软件支持等因素对参与者很重要,而僵化的数据输入则被认为是一个障碍。